Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR2285 Tablets Combined With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects
Latest Information Update: 04 Jul 2022
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; SHR 2285 (Primary) ; Ticagrelor (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors Jiangsu Hengrui Medicine Co.
- 30 Jun 2022 Status changed from active, no longer recruiting to completed.
- 29 Oct 2021 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2021 Status changed from not yet recruiting to recruiting.